Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

NCT00712062 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Lack of accrual

Conditions

Interventions

Sponsor

University of Florida